Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 11Gynecologic 2Gastrointestinal 2Thoracic 1Sarcoma 1Other neoplasm 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Melanoma 49Carcinoma, Basal Cell 12Neoplasm Metastasis 9Lymphoma, T-Cell, Cutaneous 9Skin Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Lymphoma, T-Cell 5Colorectal Neoplasms 5Carcinoma, Merkel Cell 5Uveal Melanoma 4Uterine Cervical Neoplasms 4Mycosis Fungoides 4Lymphoma 4Lung Neoplasms 4Carcinoma, Renal Cell 4Urinary Bladder Neoplasms 3Sarcoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Follicular 3Keratosis, Actinic 3Endometrial Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Sezary Syndrome 2Prostatic Neoplasms 2

Interventions

pembrolizumab 4motexafin gadolinium 1cabozantinib 1Vorinostat 1Taxes 1Specimen Handling 1Ritonavir 1Radiotherapy 1Pemetrexed 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Indinavir 1Drug Therapy 1Doxorubicin 1Cisplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × Biopsy × Dermatologic × Clear all
NCT05136196 2026-06-03

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

National Cancer Institute (NCI)

Phase 2 Recruiting
150 enrolled
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Melanoma, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡